Purchase Order 75N95020P00158
Award Date
4/15/20
Potential Completion Date
7/8/20
Potential Value
$25K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Wuxi Apptec (Hongkong) LIMITED
Ultimate Awardee
Not listed
NAICS Category
325199 - All Other Basic Organic Chemical Manufacturing
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Hong Kong International Airport, 1 Sky Plaza Rd, Chek Lap Kok, Hong Kong
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Wuxi Apptec (Hongkong) LIMITED, a global provider of research and development services to the pharmaceutical and healthcare industry. The $17,750.00 firm fixed price purchase order is for the synthesis of six analogues of OSMI-4A, with a period of performance from August 28, 2020 to November 6, 2020. The...
This is a $115,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED, a global contract research and development organization. The contract is for the provision of chemical compounds, small molecule compound libraries, analogues, and other materials to support NIDA's research activities, which may include testing anti-cancer drug candidates, lowering...
This firm-fixed-price purchase order contract was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED. The contract provides for the synthesis and delivery of 0.2 grams of the small molecule Marizomib, with a purity of 95% or above, as well as a report detailing the synthesis and purity information. The contract has a ceiling value of $10,800.00 and a performance period of approximately 20 weeks from...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Wuxi Apptec (Hongkong) LIMITED, a for-profit limited liability company. The contract has a ceiling value of $4,800.00 and a completion date of February 28, 2019. The contract is for the synthesis of a custom drug called KD025. There is no set-aside designation for this award. Through prior prime contract awards, Wuxi Apptec (Hongkong)...
This is a federal contract award from the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED. The contract, valued at $128,000.00, is for the synthesis of 2R,6R-hydroxynorketamine hydrochloride. The contract is a firm fixed price purchase order with a completion date of January 21, 2017. The contract does not have a set-aside designation. Wuxi Apptec (Hongkong) LIMITED is a global contract research and development...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences to AAT Bioquest, Inc., a minority-owned, for-profit, woman-owned small business, and Asian-Pacific American-owned manufacturer of goods. The contract, valued at $161,032.00, is for products or services related to the NIH's mission of accelerating the translation of research to improve human health. The contract does not have a set-aside designation and...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to A1 Biochem Labs LLC, a small business, for the purchase of 34 intermediate chemical compounds in 5g quantities with purity greater than 95%. The total potential value of the award is $112,350.00. This requirement was set aside for total small business participation and is part of the agency's Coronavirus COVID-19...
This firm-fixed-price purchase order, valued at $24,263.00, was awarded by the Food and Drug Administration (FDA) to Wuxi Apptec (Hongkong) LIMITED, a global provider of R&D and manufacturing services for the pharmaceutical and healthcare industry. The contract supports the mission of the Division of Toxicology (DOT) within the Office of Applied Research and Safety Assessment (OARSA) at the FDA's Center for Food Safety and Applied Nutrition (CFSAN). Wuxi Apptec will provide chemical...
<p>This is a $92,334.95 firm fixed price purchase order contract awarded by the National Center for Advancing Translational Sciences, a civilian agency, to Apexbio Technology, LLC, a small business, for the delivery of 2,234 compounds of 5mg size. The contract has a completion date of July 20, 2015. This contract award is not associated with a larger contract vehicle.</p>
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $29,820 firm fixed price purchase order to Medchemexpress LLC to deliver forty-four bioactive compounds for replenishment and expansion of the Mechanism Interrogation PlatE 6.0 screening library. The compounds will support the Center's high-capacity robotic platform used to screen drug combinations and further its chemogenomic screening capabilities. Delivery...